Although the relationship between BRAF mutation and PTC clinicopathology and prognosis is controversial, it has been recognized as a “specific gene” of PTC; notably, the combination of thyroid nodule fine needle aspiration and BRAF mutation detection can significantly improve the detection rate of PTCs [53]. This evidence concerns the gene BRAF and thyroid gland disorder.